How did ICCM's revenue and expenses trend in Q4 2024 compared to previous quarters?

**IceCure Medical's (ICCM) revenue and expenses trends in Q4 2024 compared to previous quarters show a company that is experiencing growth in revenue but continues to operate at a loss.** 1. **Revenue Trend**: ICCM's revenue for Q4 2024 was $875,000. Comparing this to the previous quarter's revenue of $1.01 million for Q2 2024, there is a decline. However, when compared to Q3 2024, which had revenue of $662,000, there is a noticeable increase. This indicates a seasonal or fluctuating revenue pattern with a peak in the second quarter and a decline in the fourth quarter. |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |ICCM|ICCM.O|IceCure Medical|2023 Q4|33.65282215122471|1255000|186| |ICCM|ICCM.O|IceCure Medical|2024 Q1|4.647887323943662|743000|186| |ICCM|ICCM.O|IceCure Medical|2024 Q2|7.897545357524013|1011000|186| |ICCM|ICCM.O|IceCure Medical|2024 Q3|102.44648318042813|662000|186| 2. **Expense Trend**: There are no available data on ICCM's expenses for Q4 2024. However, the company has reported a net loss of $4.15 million for Q3 2024, which suggests that the expenses exceed the revenue at that time. Without specific data for Q4 2024, we cannot comment on the trend of expenses during that quarter. 3. **Profitability**: ICCM has not yet achieved profitability, as evidenced by the net losses reported in previous quarters. The sustainability of the stock's immediate price movement will largely depend on management's commentary on the earnings call and the company's future earnings expectations. 4. **Growth Prospects**: Despite the lack of profitability, ICCM has reported a 36% sales growth in the first nine months of 2024 for its ProSense consoles and disposable probes, which is a positive sign for future revenue potential. Additionally, the company's gross profit for the nine months ended September 30, 2024, increased by 41% to $1.03 million, indicating improved profitability in certain aspects of the business. In conclusion, while ICCM has shown growth in revenue and improved gross profit in certain periods, the company's expenses currently exceed its revenue, resulting in net losses. The trend of revenue and expenses in Q4 2024 compared to previous quarters is mixed, with a decline in revenue compared to Q2 2024 but an increase compared to Q3 2024. The company's future prospects appear promising with sales growth and increased gross profit, but profitability remains a challenge.